Vaidya, R., Till, C., Henry, N. L., Fisch, M. J., Hershman, D. L., & Unger, J. M. (2024). Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07523-3

Henneghan, A. M., Van Dyk, K. M., Haywood, D., Patel, M., Franco-Rocha, O. Y., Bang, S., Longley, T., Tasker, R., Kaufmann, T., Paolillo, E. W., Moore, R. C., & Hart, N. H. (2024). Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07479-4

Rosenberg, S. M., Zeng, C., An, A., Ssebyala, S. N., Stein, T., Lombardo, G., Walker, D., Mercurio, A. M., Elreda, L., Taiwo, E., Hershman, D. L., & Pinheiro, L. C. (2024). Characterizing “collateral damage” in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City. Breast Cancer Research and Treatment, 207(1), 129–141. https://doi.org/10.1007/s10549-024-07347-1

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2024). Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 206(3), 519–526. https://doi.org/10.1007/s10549-024-07337-3

McCarthy, A. M., Ehsan, S., Hughes, K. S., Lehman, C. D., Conant, E. F., Kontos, D., Armstrong, K., & Chen, J. (2024). Feasibility of risk assessment for breast cancer molecular subtypes. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07404-9

Chen, Y., Markowitz, J. C., Blanco, C., Hershman, D. L., Zhang, J. T., & Hellerstein, D. J. (2024). Geographical distance predicts psychiatric treatment retention for Hispanic women with comorbid major depression and breast cancer. Breast Cancer Research and Treatment, 205(2), 249–256. https://doi.org/10.1007/s10549-024-07250-9

Accordino, M. K., Lee, S., Leu, C. S., Levin, B., Trivedi, M. S., Crew, K. D., Kalinsky, K., Raghunathan, R., Faheem, K., Harden, E., Taboada, A., de Oliveira, B. D., Larson, E., Franks, L., Honan, E., Law, C., & Hershman, D. L. (2023). Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer. Breast Cancer Research and Treatment, 204(1), 49–59. https://doi.org/10.1007/s10549-023-07172-y

Daniel, O., Ashrafi, A., Muthoni, M. A., Njoki, N., Eric, H., Marilynn, O., Faith, A. B., Beth, W. G., Nyakio, M., Odero-Marah, V., Ragin, C., & Llanos, A. A. M. (2023). Delayed breast cancer presentation, diagnosis, and treatment in Kenya. Breast Cancer Research and Treatment, 202(3), 515–527. https://doi.org/10.1007/s10549-023-07067-y

Yeh, C., Zhou, M., Bapodra, N., Hershman, D., Espinal, E., Moran, M., Rivero, M., Fojo, A. T., & Bates, S. E. (2023). Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials. Breast Cancer Research and Treatment, 204(1), 39–47. https://doi.org/10.1007/s10549-023-07131-7

Kantor, E. D., O’Connell, K., Ergas, I. J., Valice, E., Roh, J. M., Bhimani, J., Heon, N., Griggs, J. J., Lee, J., Bowles, E. J., Rivera, D. R., Kolevska, T., Bandera, E. V., & Kushi, L. H. (2023). Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system. Breast Cancer Research and Treatment, 203(3), 565–574. https://doi.org/10.1007/s10549-023-07126-4

Doshi, S. D., DeStephano, D., Accordino, M. K., Elkin, E., Raghunathan, R. R., Wright, J. D., & Hershman, D. L. (2023). Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer. Breast Cancer Research and Treatment, 203(1), 111–119. https://doi.org/10.1007/s10549-023-07109-5

Rillamas-Sun, E., Kwan, M. L., Iribarren, C., Cheng, R., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Huang, Y., Shen, H., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2023). Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Research and Treatment, 201(1), 117–126. https://doi.org/10.1007/s10549-023-06997-x

Phakathi, B., Dix-Peek, T., Van Den Berg, E., Dickens, C., Nietz, S., Cubasch, H., Joffe, M., Neugut, A. I., Jacobson, J. S., Ruff, P., & Duarte, R. (2023). PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study. Breast Cancer Research and Treatment, 200(3), 337–346. https://doi.org/10.1007/s10549-023-06969-1

Michel, A., Ro, V., McGuinness, J. E., Mutasa, S., Terry, M. B., Tehranifar, P., May, B., Ha, R., & Crew, K. D. (2023). Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors. Breast Cancer Research and Treatment, 200(2), 237–245. https://doi.org/10.1007/s10549-023-06966-4

Odai-Afotey, A., Lederman, R. I., Ko, N. Y., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Hershman, D. L., Crew, K. D., Keating, N. L., & Freedman, R. A. (2023). Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment, 200(1), 127–137. https://doi.org/10.1007/s10549-023-06960-w

Hershman, D. L., Chen, B. E., Sathe, C., Parulekar, W. R., Lemieux, J., Ligibel, J. A., Gelmon, K. A., Whelan, T. J., & Goodwin, P. J. (2023). Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32). Breast Cancer Research and Treatment, 200(1), 93–102. https://doi.org/10.1007/s10549-023-06922-2

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2023). Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 200(1), 85–92. https://doi.org/10.1007/s10549-023-06957-5

Sayed, S., Koka, H., Abubakar, M., Gardner, K., Salgado, R., Moloo, Z., Caban-Ureña, A. B., Rosen, D., Castro, P., Saleh, M., Shaikh, A. J., Shah, J., Figueroa, J., Makokha, F., Ha, H. K., Wang, Z., Magangane, P., Naidoo, R., Ngundo, V., … Govender, D. (2023). Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. Breast Cancer Research and Treatment, 199(2), 401–413. https://doi.org/10.1007/s10549-023-06921-3

Dix-Peek, T., Phakathi, B. P., van den Berg, E. J., Dickens, C., Augustine, T. N., Cubasch, H., Neugut, A. I., Jacobson, J. S., Joffe, M., Ruff, P., & Duarte, R. A. B. (2023). Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Research and Treatment, 199(1), 1–12. https://doi.org/10.1007/s10549-023-06886-3

Meernik, C., Jorgensen, K., Wu, C.-F., Murphy, C. C., Baker, V. L., Brady, P. C., Nitecki, R., Nichols, H. B., & Rauh-Hain, J. A. (2023). Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. Breast Cancer Research and Treatment, 198(1), 149–158. https://doi.org/10.1007/s10549-022-06857-0

Ayeni, O. A., Chiwambutsa, S., Chen, W. C., Kapungu, N., Kanji, C., Thelingwani, R., Murugan, N., Mathiba, R., Phakathi, B., Nietz, S., Ramiah, D., O’Neil, D. S., Jacobson, J. S., Ruff, P., Cubasch, H., Chirwa, T., Joffe, M., Masimirembwa, C., & Neugut, A. I. (2022). The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Research and Treatment, 197(3), 647–659. https://doi.org/10.1007/s10549-022-06835-6

Freedman, R. A., Ko, N. Y., Lederman, R. I., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Odai-Afotey, A., Kantor, O., Hershman, D. L., Crew, K. D., & Keating, N. L. (2022). Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Research and Treatment, 196(3), 623–633. https://doi.org/10.1007/s10549-022-06752-8

McCarthy, A. M., Manning, A. K., Hsu, S., Welch, M., Moy, B., Lehman, C. D., & Armstrong, K. (2022). Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Research and Treatment, 196(2), 389–398. https://doi.org/10.1007/s10549-022-06739-5

O’Shaughnessy, J., Brufsky, A., Rugo, H. S., Tolaney, S. M., Punie, K., Sardesai, S., Hamilton, E., Loirat, D., Traina, T., Leon-Ferre, R., Hurvitz, S. A., Kalinsky, K., Bardia, A., Henry, S., Mayer, I., Zhu, Y., Phan, S., & Cortés, J. (2022). Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. Breast Cancer Research and Treatment, 195(2), 127–139. https://doi.org/10.1007/s10549-022-06602-7

Geczik, A. M., Ferris, J. S., Terry, M. B., Andrulis, I. L., Buys, S. S., Daly, M. B., Hopper, J. L., John, E. M., Kurian, A. W., Southey, M. C., Liao, Y., & Genkinger, J. M. (2022). Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations. Breast Cancer Research and Treatment, 194(3), 673–682. https://doi.org/10.1007/s10549-022-06656-7

McGuinness, J. E., Ro, V., Mutasa, S., Pan, S., Hu, J., Trivedi, M. S., Accordino, M. K., Kalinsky, K., Hershman, D. L., Ha, R. S., & Crew, K. D. (2022). Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer. Breast Cancer Research and Treatment, 194(1), 35–47. https://doi.org/10.1007/s10549-022-06614-3

Kwan, M. L., Cheng, R. K., Iribarren, C., Shen, H., Laurent, C. A., Roh, J. M., Hershman, D. L., Kushi, L. H., Greenlee, H., & Rana, J. S. (2022). Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Research and Treatment, 193(3), 669–675. https://doi.org/10.1007/s10549-022-06586-4

Lin, P.-H., Chen, S.-C., Tseng, L.-M., Chang, K.-J., Huang, A.-C., Cheng, K.-C., Yang, K., Wu, H.-C., Chao, T.-Y., Chang, Y.-C., Lin, P.-C., Kuo, W.-H., Kuo, W.-L., Lin, C.-H., Chen, H.-M., Yeh, D.-C., Liu, L.-C., Liu, C.-Y., Wang, M.-Y., … Huang, C.-S. (2022). Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast Cancer Research and Treatment, 192(3), 629–637. https://doi.org/10.1007/s10549-021-06446-7

Westhoff, C. L., Guo, H., Wang, Z., Hibshoosh, H., Polaneczky, M., Pike, M. C., & Ha, R. (2022). The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. Breast Cancer Research and Treatment, 192(2), 321–329. https://doi.org/10.1007/s10549-021-06503-1